Growth Metrics

Regenerex Pharma (RGPX) Change in Accured Expenses (2011 - 2025)

Regenerex Pharma (RGPX) reported Change in Accured Expenses of $82384.0 for Q3 2025, up 221.5% year-over-year from $25625.2 in Q3 2024, and up 306.83% on a QoQ basis from $20250.0 in Q2 2025.

Regenerex Pharma (RGPX) has 13 years of Change in Accured Expenses data on file, last reported at $82384.0 in Q3 2025.

  • Quarterly Change in Accured Expenses rose 221.5% year-over-year to $82384.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $64574.0 (down 71.02% YoY) and the FY2025 annual result came in at -$8983.0, down 103.09% from the prior year.
  • Change in Accured Expenses rose to $82384.0 in Q3 2025 per RGPX's latest filing, from $20250.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $145699.0 in Q3 2023 and bottomed at -$67808.0 in Q3 2024.
  • The 5-year median for Change in Accured Expenses is $16532.0 (2021), against an average of $27492.1.
  • The widest annual swing landed in 2023, when Change in Accured Expenses tumbled 701.28%; it then surged 2186.69% in 2024.
  • Tracing RGPX's Change in Accured Expenses over 5 years: stood at $11101.0 in 2021, then soared by 52.34% to $16911.0 in 2022, then soared by 472.91% to $96885.0 in 2023, then slumped by 83.95% to $15546.0 in 2024, then soared by 429.94% to $82384.0 in 2025.
  • Per Business Quant, the three latest RGPX Change in Accured Expenses figures stand at $82384.0 (Q3 2025), $20250.0 (Q2 2025), and -$53606.0 (Q1 2025).

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 82,384.00
Sep 30, 2025 82,384.00
Jun 30, 2025 20,250.00
Jun 30, 2025 20,250.00
Mar 31, 2025 -53,606.00
Mar 31, 2025 -53,606.00
Dec 31, 2024 15,546.00
Dec 31, 2024 15,546.00
Sep 30, 2024 -67,808.00
Sep 30, 2024 -67,808.00
Jun 30, 2024 96,885.00
Jun 30, 2024 96,885.00
Mar 31, 2024 96,885.00
Mar 31, 2024 96,885.00
Dec 31, 2023 96,885.00
Dec 31, 2023 96,885.00
Sep 30, 2023 145,699.00
Sep 30, 2023 145,699.00
Jun 30, 2023 -48,814.00
Jun 30, 2023 -48,814.00
Mar 31, 2023 -4,643.00
Mar 31, 2023 -4,643.00
Dec 31, 2022 16,911.00
Dec 31, 2022 16,911.00
Sep 30, 2022 27,944.00
Sep 30, 2022 27,944.00
Jun 30, 2022 -6,092.00
Jun 30, 2022 -6,092.00
Mar 31, 2022 40,399.00
Mar 31, 2022 40,399.00
Dec 31, 2021 11,101.00
Dec 31, 2021 11,101.00
Sep 30, 2021 16,153.00
Sep 30, 2021 16,153.00
Jun 30, 2021 8,779.00
Jun 30, 2021 8,779.00
Dec 31, 2020 9,507.00
Dec 31, 2020 9,507.00
Sep 30, 2020 9,197.00
Sep 30, 2020 9,197.00
Jun 30, 2020 8,464.00
Jun 30, 2020 8,464.00
Mar 31, 2020 -41,458.00
Mar 31, 2020 -41,458.00
Dec 31, 2019 -44,249.00
Dec 31, 2019 -44,249.00
Sep 30, 2019 125,051.00
Sep 30, 2019 125,051.00
Jun 30, 2019 4,064.00
Jun 30, 2019 4,064.00
Mar 31, 2019 671.00
Mar 31, 2019 671.00
Dec 31, 2018 -14,999.00
Dec 31, 2018 -14,999.00
Sep 30, 2018 3,251.00
Sep 30, 2018 3,251.00
Jun 30, 2018 16,333.00
Jun 30, 2018 16,333.00
Mar 31, 2018 -5,856.00
Mar 31, 2018 -5,856.00
Dec 31, 2017 1,496.00
Dec 31, 2017 1,496.00
Nov 30, 2014 36,836.00
Nov 30, 2014 36,836.00
Aug 31, 2014 49,360.00
Aug 31, 2014 49,360.00
May 31, 2014 136,916.00
May 31, 2014 136,916.00
Feb 28, 2014 164,420.00
Feb 28, 2014 164,420.00
Nov 30, 2013 246,877.00
Nov 30, 2013 246,877.00
Aug 31, 2013 225,000.00
Aug 31, 2013 225,000.00
May 31, 2013 222,433.00
May 31, 2013 222,433.00
Feb 28, 2013 237,245.00
Feb 28, 2013 237,245.00
Nov 30, 2012 484,257.00
Nov 30, 2012 484,257.00
Aug 31, 2012 -19,949.00
Aug 31, 2012 -19,949.00
May 31, 2012 -255.00
May 31, 2012 -255.00
Feb 29, 2012 127,754.00
Feb 29, 2012 127,754.00
Aug 31, 2011 21,297.00
Aug 31, 2011 21,297.00